R F Breiman

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. ncbi Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients
    R F Breiman
    Centers for Disease Control and Prevention, 1600 Clifton Rd, MS C 12, Atlanta, GA 30333, USA
    Arch Intern Med 160:2633-8. 2000
  2. ncbi Clinical outcomes of meningitis caused by Streptococcus pneumoniae in the era of antibiotic resistance
    A E Fiore
    Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 30:71-7. 2000
  3. ncbi Epidemiology of emerging pneumococcal drug resistance: implications for treatment and prevention
    J C Butler
    Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Vaccine 16:1693-7. 1998
  4. ncbi Risk factors for Nipah virus encephalitis in Bangladesh
    Joel M Montgomery
    Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Emerg Infect Dis 14:1526-32. 2008
  5. ncbi Intussusception, infection, and immunization: summary of a workshop on rotavirus
    L A Kombo
    National Vaccine Program Office, Atlanta, Georgia 30333, USA
    Pediatrics 108:E37. 2001
  6. ncbi Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance
    J F Moroney
    Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 33:797-805. 2001
  7. ncbi Randomized trial of the quantitative and functional antibody responses to a 7-valent pneumococcal conjugate vaccine and/or 23-valent polysaccharide vaccine among HIV-infected adults
    D R Feikin
    Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, MS C23, Atlanta, GA 30333, USA
    Vaccine 20:545-53. 2001
  8. ncbi Application of an improved method for the recombinant k 39 enzyme-linked immunosorbent assay to detect visceral leishmaniasis disease and infection in Bangladesh
    K M Kurkjian
    Centers for Disease Control and Prevention, Division of Parasitic Diseases, Mailstop F-13, 4770 Buford Highway NE, Atlanta, GA 30341, USA
    Clin Diagn Lab Immunol 12:1410-5. 2005
  9. ncbi Risk factors for typhoid fever in a slum in Dhaka, Bangladesh
    P K Ram
    Foodborne and Diarrheal Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Epidemiol Infect 135:458-65. 2007
  10. ncbi Emergence of multidrug-resistant Salmonella enterica serotype Typhi with decreased ciprofloxacin susceptibility in Bangladesh
    M Rahman
    ICDDR, B Centre for Health and Population Research, Dhaka, Bangladesh
    Epidemiol Infect 134:433-8. 2006

Collaborators

Detail Information

Publications12

  1. ncbi Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients
    R F Breiman
    Centers for Disease Control and Prevention, 1600 Clifton Rd, MS C 12, Atlanta, GA 30333, USA
    Arch Intern Med 160:2633-8. 2000
    ..We conducted a retrospective case-control study to evaluate effectiveness of pneumococcal vaccine against invasive disease among adults with human immunodeficiency virus (HIV) infection in San Francisco, Calif, and Atlanta, Ga...
  2. ncbi Clinical outcomes of meningitis caused by Streptococcus pneumoniae in the era of antibiotic resistance
    A E Fiore
    Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 30:71-7. 2000
    ..Empirical use of vancomycin, current prevalence of drug-resistant S. pneumoniae, and degree of nonsusceptibility to cefotaxime may have influenced these findings...
  3. ncbi Epidemiology of emerging pneumococcal drug resistance: implications for treatment and prevention
    J C Butler
    Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Vaccine 16:1693-7. 1998
    ..However, the vaccine is underutilized, and a substantial reduction in the morbidity and mortality associated with invasive pneumococcal infections is unlikely until the vaccine is used more widely among persons at risk for disease...
  4. ncbi Risk factors for Nipah virus encephalitis in Bangladesh
    Joel M Montgomery
    Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Emerg Infect Dis 14:1526-32. 2008
    ..Although we cannot rule out person-to-person transmission, case-patients were likely infected from contact with fruit bats or their secretions...
  5. ncbi Intussusception, infection, and immunization: summary of a workshop on rotavirus
    L A Kombo
    National Vaccine Program Office, Atlanta, Georgia 30333, USA
    Pediatrics 108:E37. 2001
    ..This research will be essential not only for the development of safe and effective rotavirus vaccines, but for the development of other oral vaccines as well...
  6. ncbi Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance
    J F Moroney
    Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 33:797-805. 2001
    ..Factors other than resistance, such as severity of illness at presentation and advance directive status ("do not resuscitate" orders), appear to have a stronger influence on pneumococcal pneumonia outcomes...
  7. ncbi Randomized trial of the quantitative and functional antibody responses to a 7-valent pneumococcal conjugate vaccine and/or 23-valent polysaccharide vaccine among HIV-infected adults
    D R Feikin
    Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, MS C23, Atlanta, GA 30333, USA
    Vaccine 20:545-53. 2001
    ..05). The second dose with either conjugate or polysaccharide following the first conjugate dose, however, produced no further increase in immune responses...
  8. ncbi Application of an improved method for the recombinant k 39 enzyme-linked immunosorbent assay to detect visceral leishmaniasis disease and infection in Bangladesh
    K M Kurkjian
    Centers for Disease Control and Prevention, Division of Parasitic Diseases, Mailstop F-13, 4770 Buford Highway NE, Atlanta, GA 30341, USA
    Clin Diagn Lab Immunol 12:1410-5. 2005
    ..We hypothesize that individuals with antibody levels greater than the 99th percentile of the negative controls but less than the cutoff point for kala-azar have asymptomatic leishmanial infections...
  9. ncbi Risk factors for typhoid fever in a slum in Dhaka, Bangladesh
    P K Ram
    Foodborne and Diarrheal Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Epidemiol Infect 135:458-65. 2007
    ..The protective effect of using latrines, particularly among young children, should be investigated further...
  10. ncbi Emergence of multidrug-resistant Salmonella enterica serotype Typhi with decreased ciprofloxacin susceptibility in Bangladesh
    M Rahman
    ICDDR, B Centre for Health and Population Research, Dhaka, Bangladesh
    Epidemiol Infect 134:433-8. 2006
    ..All strains were susceptible to ceftriaxone. The emergence of MDR S. Typhi with decreased ciprofloxacin susceptibility will further complicate the therapy of typhoid fever because of the lack of optimum treatment guidelines...
  11. ncbi Prevalence of sputum smear-positive tuberculosis in a rural area in Bangladesh
    K Zaman
    ICDDR, B, Centre for Health and Population Research, Dhaka, Bangladesh
    Epidemiol Infect 134:1052-9. 2006
    ..The higher prevalence of persistent cough and AFB-positive sputum among males need further exploration. Factors responsible for higher prevalence of TB in clusters should be investigated...
  12. ncbi Fluoroquinolone-resistant Shigella dysenteriae type 1 in northeastern Bangladesh
    A Naheed
    ICDDR, B: Centre for Health and Population Research, Dhaka, Bangladesh
    Lancet Infect Dis 4:607-8. 2004